Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 5, 2024 to Discuss Your Rights - MRNS

Core Points - The Gross Law Firm is notifying shareholders of Marinus Pharmaceuticals, Inc. regarding a class action lawsuit related to misleading statements made by the company during a specified class period [4][5] - Allegations include that the defendants understated the risks associated with the RAISE trial and failed to disclose potential consequences of not meeting early-stopping criteria, which misled investors about the company's operations and prospects [2] Group 1 - The class period for the lawsuit is from March 17, 2021, to May 7, 2024 [5] - Shareholders are encouraged to register for the class action and can monitor the case's progress through a portfolio monitoring software [5][6] - The deadline for shareholders to seek lead plaintiff status is August 5, 2024 [6] Group 2 - The Gross Law Firm aims to protect investors' rights and seeks recovery for losses incurred due to false or misleading statements by companies [3] - The firm emphasizes the importance of responsible business practices and corporate citizenship [3]